However, there is little evidence for correlation between CD29 levels and patient outcome, possibly because up-regulation of CD29 has also been correlated with lymph node metastasis and depth of invasion in CRC [106]. The gene discussed is ITGB1; the disease is metastatic malignant neoplasm in the lymph nodes.